Filing Details
- Accession Number:
- 0000899243-22-029023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-17 17:36:17
- Reporting Period:
- 2022-08-15
- Accepted Time:
- 2022-08-17 17:36:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1847529 | Joy Liu | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-08-15 | 206 | $300.26 | 13,146 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 698 | $301.63 | 12,448 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 100 | $302.35 | 12,348 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 700 | $303.99 | 11,648 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 1,743 | $305.01 | 9,905 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-15 | 300 | $305.57 | 9,605 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
- Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $300.26 (range $300.00 to $300.28).
- Open market sales reported on this line occurred at a weighted average price of $301.63 (range $301.23 to $302.01).
- Open market sales reported on this line occurred at a weighted average price of $303.99 (range $303.48 to $304.46).
- Open market sales reported on this line occurred at a weighted average price of $305.01 (range $304.54 to $305.53).
- Open market sales reported on this line occurred at a weighted average price of $305.57 (range $305.55 to $305.58).